Altre lingue Dr. Lal PathLabs Limited

Azioni

LALPATHLAB

INE600L01024

Prestatari di assistenza sanitaria

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:05:08 15/05/2026			Variaz. 5gg	Var. 1 gen.
1.602,90 ^INR	+0,17%		-2,84%	+8,11%

04/05	Dr. Lal PathLabs Limited: Nomura mantiene la raccomandazione Buy	ZM
01/05	Dr. Lal PathLabs Limited (NSEI:LALPATHLAB) ha perfezionato l'acquisizione di Shahbazkers Diagnostic Centre Private Limited.	CI

Altre lingue

01/05	Dr. Lal PathLabs Limited completed the acquisition of Shahbazkers Diagnostic Centre Private Limited.
30/04	India's Dr Lal Path Labs posts quarterly profit fall on tax expense
30/04	Lal PathLabs to buy 100% stake in ShahbazKers Diagnostic Centre
30/04	Lal PathLabs March-quarter consol net profit 1.31 billion rupees
30/04	India's Dr Lal Path Labs posts quarterly profit fall on tax expense
30/04	Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
30/04	Dr. Lal PathLabs Limited agreed to acquire Shahbazkers Diagnostic Centre Private Limited for INR 200 million.
30/01	Dr. Lal PathLabs Consolidated Profit Declines in Fiscal Q3, Declares Third Interim Dividend
30/01	Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
30/01	Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong
30/01	Dr. Lal PathLabs Limited Approves the Declaration of Third Interim Dividend for the Financial Year 2025 - 2026, Payment Shall Be on February 5, 2026
30/01	Dr. Lal PathLabs Q3 consol net profit 905 million rupees
08/01	Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD Test in India
07/01	Cardio Diagnostics Holdings, Inc, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD Test in India
07/01	Top Premarket Gainers
06/01	Dr. Lal PathLabs Limited Launches Sovaaka
06/01	Dr. Lal PathLabs Launches New Diagnostic Experience Center in Gurugram, India
22/12	Indian Equities Extend Gains on Monday as Rupee Recovery, Foreign Inflows Lift Markets
22/12	Dr. Lal PathLabs Allotts Bonus Equity Shares in 1:1 Ratio
26/11	Dr. Lal PathLabs Opens Complement Testing Lab in India
26/11	Dr. Lal PathLabs Announces the Launch of India's First Dedicated Complement Testing Laboratory
31/10/25	Dr. Lal PathLabs' Fiscal Q2 Profit Rises; Declares Second Interim Dividend
31/10/25	Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
31/10/25	Dr. Lal Pathlabs Limited Declares Second Interim Dividend for the Financial Year 2025-26
24/10/25	Lal Pathlabs to consider issuance of Bonus Shares